Previous studies showed that patients with overexpression of N-Myc downregulated gene 1 (NDRG1) in GBM tumor cells exhibited better prognoses, and its downregulation increased the expression level of glycogen synthase kinase 3β (GSK3β), which promotes cell proliferation [17]. Here, GSK3B is linked to glioblastoma.